Liquid Biopsy for Noncoding RNA Improves Cancer Detection
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Andy Lundin | Aug 31, 2023 | Cancer |
Researchers are developing more accurate and powerful liquid biopsy technologies that take advantage of signals from RNA “dark matter.”
Read MorePosted by Andy Lundin | Aug 31, 2023 | Cardiovascular |
A new study demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM).
Read MorePosted by Andy Lundin | Aug 30, 2023 | Disease States |
Researchers developed a test that detects Parkinson’s, potentially establishing a way to diagnose it before nervous system damage worsens.
Read MorePosted by Andy Lundin | Aug 30, 2023 | Diagnostic Technologies |
Quest Diagnostics announced that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S. FDA.
Read MorePosted by Chris Wolski | Aug 22, 2023 | Miscellaneous |
In the wake of COVID-19 there is a clear benefit for a collaborative approach between clinical labs and the entire health care enterprise.
Read More